The Advisory Committee is a multi-stakeholder group of experts representing the range of CIBMTR’s activities. The major responsibility of this committee is to advise CIBMTR’s leadership on scientific direction, policy, and priority use of resources in the context of the larger cellular therapy environment.
Responsibilities
Advisory Committee Chair:
- Leads the Advisory Committee meetings throughout their term including in-person at the annual Tandem Meetings
- Agrees and approves meeting agendas and minutes with CIBMTR leadership
- Reviews committee leadership Conflict of Interest disclosures
- Approves the appointment of CIBMTR representatives, including a Program Chair, to the Tandem Meetings Scientific Organizing Committee
- Performs functions on behalf of CIBMTR at the annual Tandem Meetings including, but not limited to; as part of the Joint Senior Leadership Team, participation on monthly planning calls, participation in the Scientific Organizing Committee, introduction of certain speakers, including the Mortimer M. Bortin lecturer and presentation of awards.
- Contribute materials to CIBMTR newsletters or other communications
- Chairs any executive sessions of the Advisory Committee that are convened
- Participates in the annual onboarding of new Advisory Committee members
- Fulfills all other roles of the Advisory Committee as needed
- Attend an onboarding prior to their first year on the Advisory Committee
- Attend at least 75 percent of the annual Advisory Committee meetings
Advisory Committee Chair-Elect:
- Replaces the chair to lead meetings in the unusual situation that the chair is unavailable or has declared a conflict of interest
- Moves to the chair role early in the event that the chair should unexpectedly leave the position
- Approves the appointment of CIBMTR representatives, including a Program Chair, to the Tandem Meetings Scientific Organizing Committee
- Participates as able in any executive sessions of the Advisory Committee that are convened
- Participates in annual onboarding of new Advisory Committee members
- Fulfills all other roles of the Advisory Committee as needed
Advisory Committee Past Chair:
- Supports the incoming chair in their role
- Participates as able in any executive sessions of the Advisory Committee that are convened
- Fulfills all other roles of the Advisory Committee as needed
Advisory Committee Member:
- Agrees and approves meeting minutes
- May be asked to contribute materials to CIBMTR newsletters or other communications
- May participate in the annual onboarding of new Advisory Committee members
- Fulfills all other roles of the Advisory Committee as needed
- Attend an onboarding prior to their first year on the Advisory Committee
- Attend at least 75 percent of the annual Advisory Committee meetings
Advisory Committee Member representing a sub-committee (Consumer Advocacy Committee, Nominating Committee):
- Represents their sub-committee on the Advisory Committee including raising topics of interest to the committee
- Fulfills all other roles of the Advisory Committee as needed
Membership
- Individuals appointed to the Advisory Committee should represent stakeholders broadly including:
- Expertise in adult and pediatric clinical care;
- Expertise in hematopoietic cell transplantation and cellular and gene therapies;
- Expertise in donor selection and graft collection and manipulation;
- Representation of US and non-US centers;
- Familiarity with CIBMTR operations; and
- Representation of patient, family, and donor interests. Members to represent donor centers and collection centers are appointed by the Chief Scientific Director, CIBMTR NMDP
Meetings
In-person Advisory Committee meetings are conducted once annually during the Tandem Meetings of ASTCT & CIBMTR. Additional meetings take place by conference call at least two times annually. for review of the research agenda. Meetings are open to the public and federal representatives, except on rare occasions when deliberations pose a conflict of interest (such as in-center confidentiality). Ad hoc task forces meet by teleconference as needed to address specific issues.
Chair
- Sumithira Vasu, MBBS, MD, Ohio State Medical Center, James Cancer Center, Columbus, OH
Immediate Past Chair
-
Michael Verneris, MD, University of Colorado - Children's Hospital, Aurora, CO
At Large Members
- Rachel Cook, MD, MS, Oregon Health and Science University, Portland, OR
- Christopher Dandoy, MD, MS, Cincinnati Children's Hopsital Medical Center, Cincinnati, OH
- Theresa Hahn, PhD, Roswell Park Cancer Institute, Buffalo, NY
- Betty Hamilton, MD, BS, Cleveland Clinic Foundation, Cleveland, OH
- Shannon Maude, MD, PhD, Children’s Hospital of Philadelphia, PA
- Rayne Rouce, MD, Baylor College of Medicine Center for Cell and Gene Therapy, Houston, TX
International Members
- Sebastian Galeano, MD, British Hospital & Faculty of Medicine, Montevideo, Uruguay
- Andres Gomez-De Leon, MD, Hospital Universitario Dr. José E. González, Universidad Autónoma de Nuevo León, Nuevo Leon, Mexico
- Nada Hamad, BSc, MSc, MBBS, St. Vincent's Hospital, Darlinghurst, Australia
- Arjun Law, MBBS, MD, DM, Princess Margaret Cancer Center, Toronto, Canada
Committee Chair Members
- Adoptive Cellular Therapies Stakeholders Council Chair: Frederick Locke, MD, Moffitt Cancer Center, Tampa, FL
- Consumer Advocacy Committee Co-Chairs:
- Rebecca Higgins, MSW, Milwaukee, WI
- Robert Lisac, Jacksonville, FL
- Nominating Committee Chair: Amy Keating, MD, Dana-Farber Cancer Institute, Boston, MA
Other Appointed Members
- Bioethicist: Gregory Abel, MD, MPH, Dana Farber Cancer Institute, Boston, MA
- Collection Center Representative: Huy Pham, MD, MPH, NMDP, Seattle, WA
- Cord Blood Bank Representative: Wouter Van’t Hof, PhD, Cleveland Cord Blood Center, Warrensville Heights, OH
Ex Officio Voting Members
- ASTCT President: David Porter, MD
- ONR Representative: TBD
- MCW/NCI Project Officer: Lori Henderson, PhD
- MCW/NHLBI Project Officer: Nancy DiFronzo, PhD
- MCW/NIAID Project Officer: Linda Griffith, MD, PhD
Ex Officio Non-Voting Members
- Chief Scientific Director, CIBMTR MCW; Co-PI of the CIBMTR Infrastructure U24, CIBMTR MCW: Bronwen Shaw, MD, PhD
- Chief Scientific Director, CIBMTR NMDP; Senior Vice President, Health Equity, NMDP: Jeffery Auletta, MD
- Chief Statistical Director, CIBMTR MCW: Kwang Woo Ahn, PhD
- Executive Scientific Director, Policy and Governance, CIBMTR MCW: Patricia Steinert, PhD, MBA
- Vice President, CIBMTR and Clinical Services, NMDP: Mary Hengen, MBA
- Senior Scientific Director and Principal Investigator of the SCTOD, CIBMTR MCW: J. Douglas Rizzo, MD, MS
- Vice President of Research and Senior Scientific Director, CIBMTR NMDP: Steve Spellman, MBS
- Senior Scientific Director, CIBMTR MCW; Co-PI of the CIBMTR Infrastructure U24, CIBMTR MCW: Marcelo Pasquini, MD, MS
- Chief Medical Officer, NMDP; Senior Scientific Director, CIBMTR NMDP: Steven Devine, MD
- Chief Executive Officer, NMDP: Amy Ronneberg
- Scientific Director Emeritus, CIBMTR MCW: Mary M. Horowitz, MD, MS
- Director, Strategic Programs, NMDP: Meggan McCann, MPH
- HRSA Contracting Officer Representatives:
- Nawraz Shawir, MBBS
- Marilyn Levi, MD